Prospective Liver Study
Completed
- Conditions
- Liver Cancer
- Registration Number
- NCT01539993
- Lead Sponsor
- Emory University
- Brief Summary
This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
- Patients diagnosed with Hepatocellular carcinoma and referred for percutaneous liver treatment.
Read More
Exclusion Criteria
- Severe liver disfunction
- Active uncontrolled infection
- Significant underlying medical of physical illness
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess efficacy of percutaneous and transarterial treatments for liver cancer. 1 month QOL questionnaire will be collected during follow up visit.
- Secondary Outcome Measures
Name Time Method long term follow up 3 months, 6 months 1year Patients will be administered QOL during 3 months, 6 months and 1 year follow up.
Trial Locations
- Locations (1)
Emory University
🇺🇸Atlanta, Georgia, United States